Destiny Pharma plc (“Destiny Pharma” or “the Company”) Further information re AGM Brighton, United Kingdom – 25 May 2021 – Destiny Pharma plc (AIM: DEST), a clinical stage innovative biotechnology […]
Wednesday May 19, 2021
Notice to Register for 2021 AGM
Destiny Pharma plc (“Destiny Pharma” or “the Company”) Notice to Register for 2021 AGM Brighton, United Kingdom – 19 May 2021 – Destiny Pharma plc (AIM: DEST) a clinical stage innovative biotechnology […]
Thursday May 6, 2021
Destiny Pharma Conference Attendance for May 2021
Destiny Pharma plc (“Destiny Pharma” or the “Company”) Destiny Pharma Conference Attendance for May 2021 Brighton, United Kingdom – 6th May 2021 – Destiny Pharma plc (AIM: DEST), a clinical […]
Tuesday May 4, 2021
Equity Development Research Note ‘Destiny Pharma: M3, another gem in the portfoli...
Please follow link below for Equity Development’s Research Note ‘Destiny Pharma: M3, another gem in the portfolio‘, released today
Tuesday May 4, 2021
Posting of Annual Report and Notice of AGM
Destiny Pharma plc (“Destiny Pharma” or “the Company”) Posting of Annual Report and Accounts, and Notice of AGM Brighton, United Kingdom – 4 May 2021 – Destiny Pharma plc (AIM: DEST) a […]